Back to Transactions
Healthcare
2016

Riverside has sold Diatron to Stratec Biomedical

Client: The Riverside Company

Client Location: United States of America

Buyer: Stratec Biomedical AG

Buyer Location: Germany

Target: Diatron Group

Target Location: Hungary

Target Description: The Diatron Group is a hematology and clinical chemistry analyzer and reagent manufacturer.

Riverside Diatron Stratec 2016

Related
Perspectives

Connect with a Senior Team Member

Meet our Senior Team

Headshot of Ulrich Desl
I build trust with my clients through integrity and clear communication. Our clients value providing them with our market insight and expertise.

Ulrich Desl

Managing Director & Co-Head of Industrials, Europe

Frankfurt

View More Transactions

Lincoln International advised Livingbridge on the sale of Fresh Tandartsen to European Dental Group, a portfolio company of Nordic Capital

Healthcare

Lincoln International advised Conversia on its sale from Inveready to Wilmington plc

Technology

Lincoln International advised Perkopolis on its sale to PerkSpot, a portfolio company of Susquehanna Growth Equity

Technology

Lincoln International advised Tages Capital on its agreement with 21 Invest to form 21 Next backed by Edizone

Financial Institutions

Lincoln International advised Truelink Capital on the agreement to sell Koch Filter, a subsidiary of Air Distribution Technologies, to Atmus Filtration Technologies

Industrials

Lincoln International advised Vos Logistics on the agreement to sell to Jacky Perrenot from Scheybeeck

Transportation & Logistics

Lincoln International advised Hidden Harbor Capital Partners on the sale of Avtron Power Solutions to Legrand

Energy Transition, Power & Infrastructure | Industrials

Lincoln International advised CapVest on the recapitalization of Curium

Healthcare
View All

Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.